Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension: Relationship to cardiovascular risk and treatment

被引：0
|
作者：
Tayebjee, MH [1 ]
Nadar, SK [1 ]
Blann, AD [1 ]
Beevers, DG [1 ]
MacFadyen, RJ [1 ]
Lip, GY [1 ]
机构：
[1] City Hosp, Univ Dept Med, Birmingham, W Midlands, England
来源：
AMERICAN JOURNAL OF HYPERTENSION | 2004年 / 17卷 / 05期
关键词：
hypertension; matrix metalloproteinase; cardiovascular risk;
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
OR53
引用
收藏
页码：23A / 23A
页数：1
相关论文
共 50 条
  • [1] The impact of cardiovascular risk reduction therapy on circulating matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension
    Tayebjee, MH
    Nader, S
    Beevers, DG
    MacFadyen, RJ
    Lip, GYH
    EUROPEAN HEART JOURNAL, 2004, 25 : 662 - 662
  • [2] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in perinatal asphyxia
    Sunagawa, Shinpei
    Ichiyama, Takashi
    Honda, Rie
    Fukunaga, Shinnosuke
    Maeba, Shinji
    Furukawa, Susumu
    BRAIN & DEVELOPMENT, 2009, 31 (08): : 588 - 593
  • [3] Modulation of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in sepsis
    Maitra, Subir R.
    Jacob, Asha
    Zhou, Mian
    Wang, Ping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 3 (03): : 180 - 185
  • [4] Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in multiple sclerosis
    Boz, Cavit
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2006, 108 (06) : 618 - 618
  • [5] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment - A substudy of Angio-Scandinavian Cardiac Outcomes Trial (ASCOT)
    Tayebjee, MH
    Nadar, S
    Blann, AD
    Beevers, DG
    MacFadyen, RJ
    Lip, GYH
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (09) : 764 - 769
  • [6] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in multiple sclerosis
    Gerlach, Raquel F.
    Tanus-Santos, Jose E.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2006, 108 (06) : 617 - 618
  • [7] Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension - Relationship to tissue doppler indices of diastolic relaxation
    Tayebjee, MH
    Nadar, SK
    MacFadyen, RJ
    Lip, GYH
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (09) : 770 - 774
  • [8] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in congestive heart failure
    Gerlach, Raquel F.
    Tanus-Santos, Jose E.
    AMERICAN HEART JOURNAL, 2006, 152 (01)
  • [9] Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer:: relationship to clinicopathological variables
    Islekel, Huray
    Oktay, Gulgun
    Terzi, Cem
    Canda, Aras Emre
    Fuzun, Mehmet
    Kupelioglu, Ali
    CELL BIOCHEMISTRY AND FUNCTION, 2007, 25 (04) : 433 - 441
  • [10] Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1: a possible role in the pathogenesis of endometriosis
    Szamatowicz, J
    Laudanski, P
    Tomaszewska, I
    HUMAN REPRODUCTION, 2002, 17 (02) : 284 - 288
12345